Global Small Volume Parenteral Market Is Anticipated To Witness High Growth Owing To Rising Prevalence Of Chronic Diseases
![]() |
small volume parenteral market |
The global small volume parenteral market consists of various solutions that
are administered intravenously through small volume dosage instead of regular
large volume parenteral solutions. Small volume parenterals are sterile
solutions usually containing mixtures of drugs and amino acids, vitamins, and
other essential components in small volume dosage amounts usually less than
100ml. These solutions find widespread applications in the treatment of
electrolyte imbalances, nutritional deficiencies, dehydration and various
chronic diseases requiring intravenous solutions. The increasing prevalence of
chronic diseases worldwide coupled with growing geriatric population prone to
various health issues are key factors driving the demand for parenteral
nutrition and small volume dosages.
The Global small volume parenteral market is estimated to be valued at US$
179.62 BN in 2024 and is expected to exhibit a CAGR of 7.3% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the global small volume parenteral market are
Fresenius Kabi AG, Baxter, Sichuan Kelun, BML Parenteral Drugs, ICU Medical,
Inc., Pfizer Inc., Becton Dickinson and Company, B. Braun Melsungen AG, WuXi
AppTec , Akums Drugs & Pharmaceuticals Ltd., Orion Corporation, Rusoma
Laboratories Private Limited, Higgs Healthcare and Syntegon Technology GmbH.
Key players
are focussing on regional expansion and new product launches
to gain greater market share. For instance, in 2023 Fresenius Kabi AG
inaugurated a new manufacturing plant in Russia to strengthen its regional
presence. Similarly, ICU Medical launched IV flush syringes with Enshield
safety features for improved safety.
North America currently dominates the global market owing to high accessibility
to healthcare facilities and growing geriatric population. However, Asia
Pacific is expected to witness fastest growth owing to rising medical tourism,
improving healthcare infrastructure and increasing expenditures on healthcare.
Key players are expanding their manufacturing footprint in Asian countries to
leverage growth opportunities in the region.
Market drivers and restraints
The growing prevalence of chronic diseases such as cancer, diabetes,
cardiovascular diseases etc. is a key factor driving the demand for parenteral
nutrition solutions. Small volume parenterals are widely used in disease
treatment procedures involving intravenous medication and therapy. According to
WHO, cancer is the second leading cause of death globally and was responsible
for nearly 10 million deaths in 2020. The increasing cancer burden worldwide is
anticipated to boost the adoption of small volume parenteral solutions in
chemotherapy procedures over the forecast period.
High costs associated with parenteral drugs and equipment can hamper the market
growth. Parenteral drugs require specialized manufacturing and quality
compliance practices which increases their production costs. Additionally,
hospitals and patients have to incur costs for equipment like infusion pumps,
medical disposables which adds to the overall treatment expenses of parenteral
therapy. This high cost factor of parenteral drugs and equipment may restrict
the market from reaching its full potential.
Segment
Analysis
The global
small volume parenteral market demand is dominated by the
cardiovascular diseases sub-segment. Cardiovascular diseases account for over
30% of the market share owing to factors such as rising prevalence of chronic
diseases like heart failure and peripheral vascular diseases across the world.
These chronic conditions require small volume parenteral drugs like isotonic
solutions for fluid replacement and maintenance and electrolyte balance in
patients. Other major sub-segments include infectious diseases, metabolic
diseases, gastroenterology, oncology and neurology. The infectious diseases
sub-segment holds the second largest share and is expanding at a steady pace
due to increasing incidence of hospital acquired infections and growing demand
for antimicrobials.
Global Analysis
Regionally, North America commands the largest share in the global small
volume parenteral market due to factors such as advanced healthcare
infrastructure, high healthcare spending and growing demand for parenteral
nutrition for diabetes and cancer treatment. Europe holds the second largest
revenue share on back of rising geriatric population susceptible to chronic
illnesses in countries like Germany, United Kingdom and France. Meanwhile, Asia
Pacific is identified as the fastest growing region in the market and will
continue to offer lucrative opportunities through 2030. This can be attributed
to increasing healthcare expenditure, rising medical tourism industry and
growing prevalence of chronic disorders in India and China. Key players are
focused on strengthening their presence in emerging economies of Asia Pacific
and Latin America regions to leverage new growth avenues.
Get more insights on this topic: https://www.ukwebwire.com/global-small-volume-parenteral-market-industry-insightstrendsglobal-small-volume-parenteral-market/
Explore
more information on this topic, Please visit: https://captionssky.com/bridging-nature-and-innovation-unravelling-the-wonders-of-synthetic-biologys-genetic-tapestry/
Comments
Post a Comment